Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a 2-Drug Antiretroviral Therapy for HIV-1 Infection

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a 2-Drug Antiretroviral Therapy for HIV-1 Infection
Authors
Keywords
-
Journal
AIDS RESEARCH AND HUMAN RETROVIRUSES
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2019-09-11
DOI
10.1089/aid.2019.0171

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.